English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16926/19260 (88%)
Visitors : 7612387      Online Users : 126
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/24241


    標題: Design and Synthesis of 5-Aminosalicylic Acid Derivatives and Flavonoids as Potential Influenza Neuraminidase Inhibitors
    作者: Chia-Wei Liao (廖家偉)
    Wen-Hsin Huang (黃文鑫)
    An-Rong Lee (李安榮)
    日期: 2011
    上傳時間: 2011-06-23 14:57:28 (UTC+8)
    摘要: Exposure to the highly pathogenic H1N1 influenza A viruses is responsible for hundred of frightened deaths in Taiwan this year and the considerable global pandemic threat. Nowadays, medicines such as Tamiflu and Relenza have proven effective in subduing flu symptoms and preventing transmission, but mutation of influenza virus is much more quickly today than they was before. Over time, we have ;en warning signals that drug-resistant influenza viruses cause illness and severe pandemics, disabling our defenses against this pathogen. The increasing drug-resistance to the existing drugs has made a priority fcfor tne need to develop more potent antiviral agents. Among many potential targets, neuraminidase (NA) appears to be an effective target for drug development. According to the X-ray crystal structure of the NA active site, developing NA inhibitors against the drug-resistant virus is feasible. Besides, several flavonoids have been reported that they had anti-influenza virus activity by inhibiting NA activities. Until now, a series of anti-influenza agents have been synthesized by human influenza viruses was examined on the basis of the maximum non-toxic concentration of the test compounds. Some of our products showed potent activity, in vitro, against H1N1 viruses. Further investigations on the mechanisms of action are inprogress.
    Appears in Collections:[藥理學院] 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會

    Files in This Item:

    File Description SizeFormat
    pp-25.pdf77KbAdobe PDF360View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback